|
WO2014070771A1
|
|
Pyrimidine nucleotides and their monophosphate prodrugs for treatment of viral infections and cancer
|
|
CA2858814A1
|
|
Hcv ns3 protease inhibitors
|
|
CA2815855A1
|
|
Novel specific hcv ns3 protease inhibitors
|
|
EP2616461A2
|
|
Potent and selective inhibitors of hepatitis c virus
|
|
EP2393815A2
|
|
Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
|
|
EP2268288A2
|
|
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
CN101878032A
|
|
Potent combinations of zidovudine and drugs that select for the K65R mutation in the HIV polymerase
|
|
CN101784557A
|
|
The azido purine nucleosides that is used for the treatment of virus infection
|
|
BRPI0813036A2
|
|
stereoselective process for preparing purine dioxolane nucleoside derivatives.
|
|
EP2004661A2
|
|
2'-fluoronucleoside phosphonates as antiviral agents
|
